Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionKendall Capital Management
Latest Disclosed Ownership61,555 shares
Latest Disclosed Value $ 3,733,311
Kendall Capital Management reports 8.40% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 24, 2026 - Kendall Capital Management filed a 13F-HR form disclosing ownership of 61,555 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $3,226,713 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 56,785 shares of Bristol-Myers Squibb Company. This represents a change in shares of 8.40% during the quarter. The current value of the position is $2,919,554 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F Bristol-Myers Squibb COM 110122108 61,555 4,770 8.40 3,733 21.91 0.7651
2026-01-16 2025-12-31 13F Bristol-Myers Squibb COM 110122108 56,785 -2,697 -4.53 3,063 14.17 0.6407
2025-11-13 2025-09-30 13F Bristol-Myers Squibb COM 110122108 59,482 3,730 6.69 2,683 3.95 0.6048
2025-07-16 2025-06-30 13F Bristol-Myers Squibb COM 110122108 55,752 8,210 17.27 2,581 -11.00 0.6825
2025-04-25 2025-03-31 13F Bristol-Myers Squibb COM 110122108 47,542 -90 -0.19 2,900 7.61 0.8520
2025-02-07 2024-12-31 13F Bristol-Myers Squibb COM 110122108 47,632 2,985 6.69 2,694 16.62 0.7883
2024-11-08 2024-09-30 13F Bristol-Myers Squibb COM 110122108 44,647 -2,295 -4.89 2,310 18.52 0.7132
2024-08-12 2024-06-30 13F Bristol-Myers Squibb COM 110122108 46,942 -1,542 -3.18 1,950 -25.87 0.6500
2024-05-10 2024-03-31 13F Bristol-Myers Squibb COM 110122108 48,484 1,743 3.73 2,629 9.63 0.9046
2024-01-26 2023-12-31 13F Bristol-Myers Squibb COM 110122108 46,741 610 1.32 2,398 119,800.00 0.9316
2023-10-31 2023-09-30 13F Bristol-Myers Squibb COM 110122108 46,131 1,022 2.27 3 0.00 1.1868
2023-07-28 2023-06-30 13F Bristol-Myers Squibb COM 110122108 45,109 275 0.61 3 -33.33 1.2645
2023-05-11 2023-03-31 13F Bristol-Myers Squibb COM 110122108 44,834 1,066 2.44 3 0.00 1.4927
2023-01-30 2022-12-31 13F Bristol-Myers Squibb COM 110122108 43,768 -1,771 -3.89 3 -99.91 1.5912
2022-11-02 2022-09-30 13F Bristol-Myers Squibb COM 110122108 45,539 1,240 2.80 3,237 -5.10 1.8836
2022-07-29 2022-06-30 13F Bristol-Myers Squibb COM 110122108 44,299 -430 -0.96 3,411 4.41 1.8786
2022-05-06 2022-03-31 13F Bristol-Myers Squibb COM 110122108 44,729 2,315 5.46 3,267 23.52 1.5790
2022-01-28 2021-12-31 13F Bristol-Myers Squibb COM 110122108 42,414 3,472 8.92 2,645 14.80 1.2555
2021-11-05 2021-09-30 13F Bristol-Myers Squibb COM 110122108 38,942 5,895 17.84 2,304 4.35 1.2458
2021-07-30 2021-06-30 13F Bristol-Myers Squibb COM 110122108 33,047 2,780 9.18 2,208 15.54 1.2414
2021-05-05 2021-03-31 13F Bristol-Myers Squibb COM 110122108 30,267 4,335 16.72 1,911 18.77 1.1824
2021-02-08 2020-12-31 13F Bristol-Myers Squibb COM 110122108 25,932 2,320 9.83 1,609 12.99 1.1736
2020-10-22 2020-09-30 13F Bristol-Myers Squibb COM 110122108 23,612 930 4.10 1,424 6.75 1.2387
2020-07-30 2020-06-30 13F Bristol-Myers Squibb COM 110122108 22,682 5,782 34.21 1,334 41.61 1.2776
2020-04-27 2020-03-31 13F Bristol-Myers Squibb COM 110122108 16,900 -3,125 -15.61 942 -26.69 1.0659
2020-01-24 2019-12-31 13F Bristol-Myers Squibb COM 110122108 20,025 2,170 12.15 1,285 41.99 1.0114
2019-11-12 2019-09-30 13F Bristol-Myers Squibb COM 110122108 17,855 2,605 17.08 905 30.78 0.7997
2019-08-09 2019-06-30 13F Bristol-Myers Squibb COM 110122108 15,250 2,285 17.62 692 11.79 0.6260
2019-05-08 2019-03-31 13F Bristol-Myers Squibb COM 110122108 12,965 4,630 55.55 619 42.96 0.5868
2019-02-13 2018-12-31 13F Bristol-Myers Squibb COM 110122108 8,335 2,535 43.71 433 20.28 0.4484
2018-10-29 2018-09-30 13F Bristol-Myers Squibb COM 110122108 5,800 5,800 360 0.3065
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.